MarketPeel
Insider Trading Intelligence
Pricing
…
JV

Joseph Walter Vazzano

ABEO
CHIEF FINANCIAL OFFICER · ABEONA THERAPEUTICS INC. · CIK 0001715291
FILING MIX · LIFETIME44%/56%
BUYS
14
SELLS
18
TOTAL VALUE
$1.00M
COMPANIES
2
ACTIVE SINCE
Mar 2022
HOLDINGS NOW
569,083
AVG SELL PX
$5.64
TRADE KIND
SHOWING 32 / 32
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Joseph Walter Vazzano, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+54.55%+2.20%-0.44%+2.64%+1.11%—
14d11+72.73%+3.49%-0.90%+4.39%-0.63%—
30d11+63.64%-0.10%+1.08%-1.18%+4.47%—
60d11+72.73%-1.32%+3.54%-4.87%-7.85%—
90d11+54.55%+1.95%+6.36%-4.41%-2.89%—
180d11(2 pending)+88.89%+15.53%+10.34%+5.19%-20.66%—
1y11(6 pending)+100.00%+27.88%+21.14%+6.74%+15.67%—
2y11(7 pending)+100.00%+52.88%+50.41%+2.46%-3.77%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABEO · 544,083 shares · as of Jun 9, 2026
0146,807293,613440,420587,2262023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 18 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
25,646$5.39$138.3K518,437Jun 9, 2026Jun 9, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
13,421$5.30$71.2K544,083Jun 9, 2026Jun 9, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
10,271$5.43$55.8K557,504Jun 8, 2026Jun 9, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
785$4.76$3.7K567,775Mar 16, 2026Mar 16, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
18,666$5.33$99.5K568,560Jan 22, 2026Jan 22, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
133,595——587,226Jan 20, 2026Jan 20, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
9,035$5.39$48.7K453,631Sep 29, 2025Oct 1, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
15,000$7.36$110.4K462,666Aug 15, 2025Aug 15, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
1,502$6.64$10.0K477,666Jul 22, 2025Jul 22, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
25,411$5.86$148.8K479,168Jul 9, 2025Jul 10, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
17,795$6.76$120.3K491,246Jun 6, 2025Jun 6, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
13,333——504,579Jun 5, 2025Jun 9, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
685$5.29$3.6K509,041Mar 14, 2025Mar 17, 2025 ↗View →
ALLR
ALLARITY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jan 22, 2025Jan 24, 2025 ↗View →
ALLR
ALLARITY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jan 22, 2025Jan 24, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
144,509——509,726Jan 21, 2025Jan 23, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
6,388$5.89$37.6K365,217Sep 28, 2024Sep 30, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
1,055$5.11$5.4K371,605Jul 21, 2024Jul 22, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
155,200——372,660Jul 8, 2024Jul 9, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
16,408$4.52$74.2K217,460Jun 5, 2024Jun 7, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASE
Chief Financial Officer
5,608$3.14$17.6K233,868Apr 25, 2024Apr 26, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
703$8.14$5.7K228,260Mar 15, 2024Mar 15, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
6,230$3.93$24.5K228,963Sep 29, 2023Sep 29, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASE
Chief Financial Officer
2,986$3.82$11.4K238,179Sep 19, 2023Sep 20, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASE
Chief Financial Officer
14$3.70$52235,193Sep 19, 2023Sep 20, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
1,187$3.73$4.4K235,179Jul 24, 2023Jul 25, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
141,908——236,366Jun 5, 2023Jun 7, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Financial Officer
792$2.60$2.1K94,458Mar 15, 2023Mar 17, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASE
Chief Financial Officer
2,500$4.00$10.0K95,250Nov 18, 2022Nov 21, 2022 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
72,750——92,750Sep 28, 2022Sep 30, 2022 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
12,000——20,000Jul 21, 2022Jul 25, 2022 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
200,000——200,000Mar 14, 2022Mar 16, 2022 ↗View →
Other insiders · ABEO
Loading peer insiders…
About this filer
CIK 0001715291
ROLE
Chief Financial Officer
PRIMARY
ABEO
COMPANIES
2
ACTIVE SINCE
Mar 2022
MARKETPEEL · /INSIDER/0001715291DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback